Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

NCT03617458 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT03617458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03617458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
August 23, 2018
Completion date
August 19, 2025
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary artery hypertension